Holders — by stockHoldings — by fund
Tetragon Partners GP Ltd
Everything this manager disclosed owning in US-listed stocks — its complete Form 13F portfolio · as of 2026-06-30 · filed with the SEC up to 45 days after quarter end · CIK 0001515070
$635.1M
disclosed book value
36
positions
53%
largest position share
Positions, as of 2026-06-30
top 39 of 36 · 13F covers long US-listed positions only — cash, bonds, private and foreign stakes are not disclosed · PUT/CALL tags = options positions (share-equivalents), not shares held
| # | Issuer | Shares | Value | % of book |
|---|---|---|---|---|
| 1 | PATHUIPATH INC | 30.9M | $336.4M | 53% |
| 2 | KGEIKOLIBRI GLOBAL ENERGY INC | 6.8M | $33.8M | 5.3% |
| 3 | AUTLAUTOLUS THERAPEUTICS LTD | 9.5M | $15.2M | 2.4% |
| 4 | LYFTLYFT INC | 1.0M | $14.6M | 2.3% |
| 5 | DFTXDEFINIUM THERAPEUTICS INC | 286,990 | $13.5M | 2.1% |
| 6 | WKWORKIVA INC | 250,000 | $12.1M | 1.9% |
| 7 | CXMSPRINKLR INC | 2.2M | $11.4M | 1.8% |
| 8 | MBXMBX BIOSCIENCES INC | 203,543 | $11.2M | 1.8% |
| 9 | ALKTALKAMI TECHNOLOGY INC | 600,284 | $10.9M | 1.7% |
| 10 | CLDXCELLDEX THERAPEUTICS INC NEW | 290,441 | $10.8M | 1.7% |
| 11 | RLAYRELAY THERAPEUTICS INC | 570,311 | $10.7M | 1.7% |
| 12 | ARWRARROWHEAD PHARMACEUTICALS IN | 130,484 | $10.6M | 1.7% |
| 13 | PHVSPHARVARIS N V | 295,627 | $10.2M | 1.6% |
| 14 | ALKSALKERMES PLC | 189,979 | $10.0M | 1.6% |
| 15 | IMVTIMMUNOVANT INC | 255,934 | $9.9M | 1.6% |
| 16 | AXSMAXSOME THERAPEUTICS INC.CALL | 35,000 | $8.6M | 1.3% |
| 17 | SLNSILENCE THERAPEUTICS PLC | 764,256 | $8.4M | 1.3% |
| 18 | DYNDYNE THERAPEUTICS INC | 356,657 | $7.9M | 1.2% |
| 19 | IONSIONIS PHARMACEUTICALS INC | 97,173 | $7.7M | 1.2% |
| 20 | AGIOAGIOS PHARMACEUTICALS INC | 205,579 | $7.6M | 1.2% |
| 21 | HRMYHARMONY BIOSCIENCES HLDGS IN | 201,036 | $7.3M | 1.2% |
| 22 | KRYSKRYSTAL BIOTECH INC | 19,668 | $7.3M | 1.2% |
| 23 | ANNXANNEXON INC | 1.2M | $7.1M | 1.1% |
| 24 | CELCCELCUITY INC | 64,110 | $6.7M | 1.1% |
| 25 | WBDWARNER BROS DISCOVERY INC | 250,000 | $6.7M | 1% |
| 26 | NKTRNEKTAR THERAPEUTICS | 86,996 | $6.1M | 1% |
| 27 | AMLXAMYLYX PHARMACEUTICALS INC | 297,926 | $5.4M | 0.8% |
| 28 | ACADACADIA PHARMACEUTICALS INC | 167,875 | $4.2M | 0.7% |
| 29 | RAREULTRAGENYX PHARMACEUTICAL INCALL | 100,000 | $3.3M | 0.5% |
| 30 | SLNSILENCE THERAPEUTICS PLCCALL | 300,000 | $3.3M | 0.5% |
| 31 | CUECUE BIOPHARMA INC | 93,819 | $3.0M | 0.5% |
| 32 | SNOWSNOWFLAKE INC | 10,000 | $2.5M | 0.4% |
| 33 | KPTIKARYOPHARM THERAPEUTICS INCCALL | 250,300 | $2.4M | 0.4% |
| 34 | ACRSACLARIS THERAPEUTICS INC | 400,000 | $2.1M | 0.3% |
| 35 | AGIOAGIOS PHARMACEUTICALS INCCALL | 50,000 | $1.9M | 0.3% |
| 36 | TECXTECTONIC THERAPEUTIC INC | 46,516 | $1.6M | 0.3% |
| 37 | GLUEMONTE ROSA THERAPEUTICS INC | 56,052 | $1.4M | 0.2% |
| 38 | TENXTENAX THERAPEUTICS INCCALL | 75,100 | $1.1M | 0.2% |
| 39 | AMLXAMYLYX PHARMACEUTICALS INCCALL | 8,500 | $152,660 | 0% |
Source: SEC Form 13F-HR, reporting period 2026-06-30. Values are the manager's filed June-30-style quarter-end marks, not live prices. Research, not investment advice.